Acotec Scientific Co., Ltd
17
5
5
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 17 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
AcoArt Litos PCB Below-the-knee Global Trial
Role: lead
AcoArt sICAS: DCB in the Treatment of Symptomatic Intracranial Atherosclerotic Stenosis
Role: lead
ACOART BTK RENEW：A Post Market Clinical Study
Role: lead
Acotec DCB Post Market Clinical Follow-up
Role: lead
AcoArt VI / Vertebral Artery Ostium Stenosis in China
Role: lead
ACOART Intracranial ISR Pilot:Intracranial DCB in the Treatment of Intracranial In-stent Restenosis
Role: lead
ACOART AVF RENEW: A Post Market Clinical Study
Role: lead
ACOART Paclitaxel SVD:Paclitaxel Coated Coronary Balloon Catheter in Treatment of Coronary Small Vessel Diseases
Role: lead
A Clinical Trial to Evaluate the Efficacy and Safety of a Spot Stent System Used in Femoropopliteal Arteries.
Role: lead
ACOART SCB BIF: Treatment of Coronary Bifurcation Lesion by Sirolimus Coated Balloon vs Paclitaxel Coated Balloon
Role: lead
Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis
Role: lead
ACOART RF CLOSURE:Radiofrequency for Varicose Veins of Lower Extremity in China
Role: lead
AcoArt III / Arterio-venous Fistula in China
Role: lead
AcoArt Ⅱ/ BTK China: Drug-eluting Balloon for Below-The-Knee Angioplasty Evaluation in China
Role: lead
AcoArt IV / SFA in China:Drug-eluting Balloon for SFA Angioplasty Evaluation in China
Role: lead
AcoArt Ⅰ / SFA China
Role: lead
Effectiveness and Safety Study of Peripheral Balloon Dilatation Catheter in Percutaneous Transluminal Angioplasty(PTA) Procedure
Role: lead
All 17 trials loaded